TY - JOUR T1 - BET 3: Emergency management of anthracycline extravasation JF - Emergency Medicine Journal JO - Emerg Med J SP - 777 LP - 779 DO - 10.1136/emermed-2012-201686.4 VL - 29 IS - 9 A2 - , Y1 - 2012/09/01 UR - http://emj.bmj.com/content/29/9/777.2.abstract N2 - A short cut review was carried out to establish whether intravenous dexrazoxane reduces the risk of tissue necrosis after extravasation of the chemotherapy agent anthracycline. One paper directly addressed the question. The clinical bottom line is that intravenous dexrazoxane appears to be safe and may reduce the risk of tissue necrosis after extravasation of anthracycline. ER -